High Growth Tech Stocks In The United Kingdom To Watch

In This Article:

The United Kingdom's FTSE 100 index recently closed lower, reflecting concerns over weak trade data from China and its impact on global markets. Despite these challenges, high-growth tech stocks in the UK present unique opportunities for investors seeking to navigate the current economic landscape.

Top 10 High Growth Tech Companies In The United Kingdom

Name

Revenue Growth

Earnings Growth

Growth Rating

STV Group

13.15%

46.78%

★★★★★☆

Gaming Realms

11.57%

22.07%

★★★★★☆

YouGov

14.29%

29.79%

★★★★★☆

Facilities by ADF

52.00%

144.70%

★★★★★☆

Redcentric

4.89%

63.79%

★★★★★☆

Windar Photonics

63.60%

126.92%

★★★★★☆

LungLife AI

100.61%

100.97%

★★★★★☆

Beeks Financial Cloud Group

24.63%

57.95%

★★★★★☆

Oxford Biomedica

20.98%

106.13%

★★★★★☆

Vinanz

113.60%

125.86%

★★★★★☆

Click here to see the full list of 47 stocks from our UK High Growth Tech and AI Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Genus

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Genus plc operates as an animal genetics company across multiple regions including North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia with a market cap of £1.32 billion.

Operations: Genus plc generates revenue primarily through its two main segments: Genus ABS, which focuses on bovine genetics and accounts for £314.90 million, and Genus PIC, specializing in porcine genetics with revenues of £352.50 million. The company has a market capitalization of £1.32 billion and operates across multiple global regions including North America, Latin America, the United Kingdom, Europe, the Middle East, Russia, Africa, and Asia.

Despite a challenging year with earnings declining by 76.3%, Genus plc is poised for recovery, with expected annual profit growth at an impressive 39.4%. This contrasts starkly with the overall UK market projection of 14.4% and signals potential resilience and adaptability within the biotech sector. The company's commitment to maintaining its dividend level amidst financial fluctuations demonstrates stability to shareholders. Looking ahead, while revenue growth predictions stand at a modest 4.1% per year, slightly above the market average of 3.7%, strategic investments in R&D could enhance future capabilities and market position in high-growth biotechnologies.

LSE:GNS Revenue and Expenses Breakdown as at Sep 2024
LSE:GNS Revenue and Expenses Breakdown as at Sep 2024

Informa

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Informa plc operates as an international events, digital services, and academic research company across the United Kingdom, Continental Europe, the United States, China, and globally with a market cap of £11.09 billion.